Registered Office:
Biocon SEZ Biocon Park,Plot No 2 & 3 Bommasandra Inds,
Bengaluru -
560099,
Karnataka, India.
Phone : 91-80-68915000/67758781 Fax:91-80-28083189
Email : investor@syngeneintl.com; Mayank.Verma@syngeneintl
Website : www.syngeneintl.com
|
Initial public offer of up to 22,000,000 equity shares of face value of Rs. 10 each ("equity shares") of Syngene International Limited ("company" or "issuer") for cash at a price of Rs. 250 per equity share (including a share premium of Rs. 240 per equity share) ("offer price") through an offer for sale by Biocon Limited (the "selling shareholder") ("offer / offer for sale") aggregating to Rs. 550 crores including a reservation of 2,000,000 equity shares for subscription by Biocon shareholders for cash at a price of Rs. 250 per equity share aggregating up to Rs. 50 crores (the "Biocon shareholders reservation portion"). The offer will constitute 11.0% of the post-offer paid-up equity share capital and the net offer shall constitute 10.0% of the post-offer paid-up equity share capital.
Offer Price : Rs. 250 per Equity share of face value of Rs. 10/- each. The offer price is 25 times of the face value.
Anchor investor offer price : Rs. 250 per equity share.
|
|
Issue |
Money Payable On |
Opens On |
Closes On |
Application |
Allotment |
27-Jul-15 |
29-Jul-15 |
250.00-0.00 |
0.00-0.00 |
|
Minimum Application for shares in Nos :
60
Further Multiples of :
60
|
|
|
Rs Cr |
Lead Managers to the Issue |
Project Cost |
37.00 |
Axis Capital Ltd
|
Project Financed through Current Offer |
550.00 |
|
Post Issue Equity Share Capital |
200.00 |
|
Issue Price |
250.00 |
|
|